Hepatitis C virus related hepatocellular carcinoma: A case control study from India

Journal of Medical Virology

Volumn 84, Issue 7, 2012, Pages 1009-1017

  Sarma, Manash Pratim ^a   Asim, Mohammad ^a   Medhi, Subhash ^a   Bharathi, Thayumanavan ^b   Kar, Premashis ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b Government Rajaji Hospital   (India)

Author keywords

Chronic hepatitis C; Cirrhosis; HCC; HCV

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ADULT; ADVANCED CANCER; AGE DISTRIBUTION; ARTICLE; CANCER RISK; CANCER SIZE; CANCER STAGING; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEPATITIS C; HUMAN; INDIA; LIFESTYLE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; NULL ALLELE; PROSPECTIVE STUDY; SMOKING;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CASE-CONTROL STUDIES; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INDIA; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

HEPATITIS C VIRUS;

EID: 84861012927     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.23290     Document Type: Article

References (47)

1. Abd El-Moneim E, Younis FA, Allam N, Gameel K, Osman M. 2008. Gene deletion of glutathione S-transferase M1 and T1 and risk factors of hepatocellular carcinoma in Egyptian patients. Egypt J Immunol 15: 125-134.
2. Acharya SK, Madan K, Dattagupta S, Panda SK. 2006. Viral hepatitis in India. Natl Med J India 19: 203-217.
3. Agarwal AK, Manvi KN, Mehta JM, Shah MJ. 1966. Clinical diagnosis of hepatoma. J Ass Phys India 14: 465-468.
4. Amarapurkar D, Dhorda M, Kirpalani A, Amarapurkar A, Kankonkar S. 2001. Prevalence of hepatitis C genotypes in Indian patients and their clinical significance. Assoc Physicians India 49: 983-985.
5. Asim M, Khan LA, Husain SA, Husain S, Sarma MP, Ahmad I, Sharma JK, Sharma A, Sharma S, Thayumanavan L, Kar P. 2010. Genetic polymorphism of glutathione S-transferases M1 and T1 in Indian patients with hepatocellular carcinoma. Dis Markers 28: 369-376.
6. Bosch FX. 1997. Global epidemiology of hepatocellular carcinoma. In: Okuda K, Tabor E, editors. Liver cancer. New York: Churchill Livingstone, pp 13-27.
7. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK. 2001. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL Conference. J Hepatol 35: 421-430.
8. Buch SC, Notani PN, Bhisey RA. 2002. Polymorphism at GSTM1, GSTM3 and GSTT1 gene loci and susceptibility to oral cancer in an Indian population. Carcinogenesis 23: 803-807.
9. Chakravarti A, Verma V, Jain M, Kar P. 2005. Characteristics of dual infection of hepatitis B and C viruses among patients with chronic liver disease: A study from tertiary care hospital. Trop Gastroenterol 26: 183-187.
10. Chandra M, Thippavuzzula R, Ramachandra Rao VV, Habib AM, Habibullah CM, Narasu L, Prameela Y, Khaja MN. 2007. Genotyping of hepatitis C virus (HCV) in infected patients from South India. Infect Genet 7: 724-730.
11. Chaudhuri S, Das S, Chowdhury A, Santra A, Bhattacharya SK, Naik TN. 2005. Molecular epidemiology of HCV infection among acute and chronic liver disease patients in Kolkata. Indian J Clin Virol 32: 38-46.
12. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159.
13. Colombo M. 1999. Hepatitis C virus and hepatocellular carcinoma. Semin Liver Dis 19: 263-269.
14. Colombo M. 2000. Hepatitis C virus and hepatocellular carcinoma. Curr Opin Gastroenterol 16: 275-281.
15. Corrao G, Busellu G, Valenti M, Torchio P, Galatola G, Di Orio F. 1994. Reproducibility of measuring lifetime alcohol consumption by a simple interview-administered questionnaire. Alcologia 6: 127-135.
16. Dhir V, Mohandas KM. 2001. Epidemiology of digestive tract cancers in India. Indian J Gastroenterol 20: 251-252.
17. Durga R, Muralikrishna P. 1994. Viral markers in hepatocellular carcinoma. Indian J Gastroenterol 13: A57.
18. Fassio E. 2010. Hepatitis C and hepatocellular carcinoma. Ann Hepatol 9: 119-22.
19. Gelatti U, Covolo L, Talamini R, Tagger A, Barbone F, Martelli C, Cremaschini F, Franceschi S, Ribero ML, Garte S, Nardi G, Donadon V, Donato FN. 2005. Acetyltransferase-2, glutathione S-transferase M1 and T1 genetic polymorphisms, cigarette smoking and hepatocellular carcinoma: A case-control study. Int J Cancer 115: 301-306.
20. Hayes JD, Pulford DJ. 1995. The glutathione S-transferase supergene family: Regulation of GST and the contribution of the isoenzymes to cancer chemoprevention and drug resistance. Crit Rev Biochem Mol Biol 30: 445-600.
21. Hosmer DW, Lemeshow S. 1989. Applied logistic regression. New York: Wiley, pp 25-175.
22. Jacobson IM, Davis GL, El-Serag H, Negro F, Trépo C. 2010. Prevalence and challenges of liver diseases in patients with chronic hepatitis C virus infection. Clin Gastroenterol Hepatol 8: 924-933.
23. Jain M, Kumar S, Rastogi N, Lal P, Ghoshal UC, Tiwari A, Pant MC, Baiq MQ, Mittal B. 2006. GSTT1, GSTM1 and GSTP1 genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esophageal cancer patients from North India. Cancer Lett 242: 60-67.
24. Jayant K, Rao RS, Nene BM, Dale PS. 1994. Rural Cancer Registry at Barshi: Report 1988-92. Barshi: Rural Cancer Registry.
25. Kar P, Budhiraja S, Narang A, Das BC, Panda SK, Chakravorty A. 1997. Comparative evaluation of serology and polymerase chain reaction for hepatitis C viral infection in liver diseases. Indian J Gastroenterol 16: 118-119.
26. Khaja MN, Madhavi C, Thippavazzula R, Nafeesa F, Habib AM, Habibullah CM, Guntaka RV. 2006. High prevalence of hepatitis C virus infection and genotype distribution among general population, blood donors and risk groups. Infect Genet Evol 6: 198-204.
27. Kim KA, Lee JS, Jung ES, Kim JY, Bae WK, Kim NH, Moon YS. 2006. Usefulness of serum alpha-fetoprotein (AFP) as a marker for hepatocellular carcinoma (HCC) in hepatitis C virus related cirrhosis: Analysis of the factors influencing AFP elevation without HCC development. Korean J Gastroenterol 48: 321-326.
28. Kobayashi M, Suzuki F, Akuta N, Suzuki Y, Sezaki H, Yatsuji H, Kawamura Y, Hosaka T, Kobayashi M, Arase Y, Ikeda K, Mineta R, Iwasaki S, Watahiki S, Miyakawa Y, Kumada H. 2009. Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferases levels. Scand J Gastroenterol 44: 975-983.
29. Kumar A, Sreenivas DV, Nagarjuna YR. 1995. Hepatocellular carcinoma. The Indian scenario. Indian J Gastroenterol 14: A95.
30. Lok AS, McMahon BJ. 2009. Chronic hepatitis B: Update 2009. Hepatology 50: 661-662.
31. Narahari S, Juwle A, Basak S, Saranath D. 2009. Prevalence and geographic distribution of Hepatitis C Virus genotypes in Indian patient cohort. Infect Genet Evol 9: 643-645.
32. National Cancer Registry Programme Annual Report. 1987. New Delhi: Indian Council of Medical Research, 1990.
33. Park YM. 2002. Hepatocellular carcinoma in Asia. In: Sarin SK, Okuda K, editors. Hepatitis B and C. Carrier to cancer. India: Elsevier Sciences, pp 268-271.
34. Paul SB, Chalamalasetty SB, Vishnubhatla S, Madan K, Gamanagatti SR, Batra Y, Gupta SD, Panda SK, Acharya SK. 2009. Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India. Oncology 77: 162-171.
35. Pyrsopoulos N, Reddy RK. 2002. Hepatocellular carcinoma in Asia. In: Sarin SK, Okuda K, editors. Hepatitis B and C. Carrier to cancer. India: Elsevier Sciences, pp 363-364.
36. Rebbeck TR. 1997. Molecular epidemiology of the human glutathione S-transferase genotypes GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev 6: 733-743.
37. Saini N, Bhagat A, Sharma S, Duseja A, Chawla Y. 2006. Evaluation of clinical and biochemical parameters in hepatocellular carcinoma: Experience from an Indian center. Clin Chim Acta 371: 183-186.
38. Saneto H, Kobayashi M, Kawamura Y, Yatsuji H, Sezaki H, Hosaka T, Akuta N, Suzuki F, Suzuki Y, Arase Y, Ikeda K, Kumada H. 2008. Clinicopathological features, background liver disease, and survival analysis of HCV-positive patients with hepatocellular carcinoma: Differences between young and elderly patients. J Gastroenterol 43: 975-981.
39. Sarin SK, Thakur V, Guptan RK, Saigal S, Malhotra V, Thyagarajan SP. 2001. Profile of hepatocellular carcinoma in India: An insight into the possible etiologic associations. Gastroenterol Hepatol 16: 666-673. 484.
40. Singh SV, Goyal SK, Chowdhury BL. 1971. Primary carcinoma of liver in Udaipur. J Ass Phys India 19: 693-695.
41. Singh S, Malhotra V, Sarin SK. 2004. Distribution of hepatitis C virus genotypes in patients with chronic hepatitis C infection in India. Indian J Med Res 119: 145-148.
42. Srivastava DS, Mandhani A, Mittal B, Mittal RD. 2005a. Genetic polymorphism of glutathione S-transferase genes (GSTM1, GSTT1 and GSTP1) and susceptibility to prostate cancer in Northern India. BJU Int 95: 170-173.
43. Srivastava DS, Mishra DK, Mandhani A, Mittal B, Kumar A, Mittal RD. 2005b. Association of genetic polymorphism of glutathione S-transferase M1, T1, P1 and susceptibility to bladder cancer. Eur Urol 48: 339-344.
44. Stankovic-Djordjevic D, Djordjevic N, Tasic G, Dinic M, Karanikolic A, Pesic M. 2007. Hepatitis C virus genotypes and the development of hepatocellular carcinoma. J Dig Dis 8: 42-47.
45. Sundaram C, Reddy CRRM, Venkataramana G, Banerjee S, Venkatratnam G, Swarnakumari G, 1990. Hepatitis B surface antigen, hepatocellular carcinoma and cirrhosis in South India-an autopsy study. Indian J Pathol Microbial 33: 334-338.
46. Takata A, Kuromatsu R, Ando E, Iwamoto H, Fukushima N, Sumie S, Torimura T, Sata M. 2010. HCC develops even in the early stage of chronic liver disease in elderly patients with HCV infection. Int J Mol Med 26: 249-256.
47. Wiencke JK, Kelsey KT, Lamela RA, Toscano WA. 1990. Human glutathione S-transferase efficiency as a marker of susceptibility to epoxide-induced cytogenetic damage. Cancer Res 50: 1585-1590.